Organon & Co. (OGN) Income Statement
OGN 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsOGN revenue and net income
Where OGN's revenue goes
2025Each bar shows an amount and its share of revenue. OGN kept 3.0% of revenue as net income.
OGN profit margins
OGN growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −2.9% | +0.2% | −1.0% | — |
| Gross profit | −9.5% | −4.7% | −5.3% | — |
| Operating income | −13.5% | −9.0% | −14.7% | — |
| Net income | −78.4% | −41.1% | −38.7% | — |
| EPS (diluted) | −10.9% | −10.1% | −15.6% | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
OGN quarterly EPS vs estimates
Organon beat the analyst EPS estimate in 4 of the last 8 quarters. Next report: November 9, 2026 (estimate $0.95).
OGN income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.22B | $6.40B | $6.26B | $6.17B | $6.30B | $6.53B | $7.78B | $9.78B | $10.50B |
| Cost of revenue | $2.85B | $2.69B | $2.52B | $2.29B | $2.38B | $2.12B | $2.27B | $4.69B | $4.59B |
| Gross profit | $3.36B | $3.71B | $3.75B | $3.88B | $3.92B | $4.41B | $5.50B | $5.08B | $5.91B |
| Research & development | $366.0M | $469.0M | $528.0M | $471.0M | $443.0M | $210.0M | $220.0M | $365.0M | $355.0M |
| Sales, general & admin | $1.72B | $1.76B | $1.89B | $1.70B | $1.43B | $1.36B | $1.44B | $2.01B | $2.29B |
| Total operating expenses | $2.09B | $2.23B | $2.42B | $2.17B | $2.01B | $1.57B | $1.66B | $2.38B | $2.64B |
| Operating income | $1.28B | $1.49B | $1.33B | $1.71B | $1.92B | $2.85B | $3.85B | $2.71B | $3.27B |
| Interest expense | $504.0M | $520.0M | $527.0M | $422.0M | $258.0M | $6.0M | $6.0M | $45.0M | $21.0M |
| Income before taxes | $425.0M | $807.0M | $673.0M | $1.12B | $1.53B | $2.75B | $3.70B | $2.73B | $3.10B |
| Income taxes | $238.0M | −$57.0M | −$350.0M | $205.0M | $178.0M | $496.0M | $390.0M | $576.0M | $1.30B |
| Net income | $187.0M | $864.0M | $1.02B | $917.0M | $1.35B | $2.16B | $3.22B | $2.15B | $1.80B |
| EBITDA | $1.29B | $1.60B | $1.44B | $1.76B | $1.98B | $2.99B | $3.92B | $4.38B | $5.08B |
| EPS (diluted) | $3.66 | $4.11 | $4.14 | $5.03 | $6.34 | $8.53 | $12.67 | — | — |
| Gross margin | 54.1% | 58.0% | 59.8% | 62.8% | 62.2% | 67.6% | 70.8% | 52.0% | 56.3% |
| Operating margin | 20.7% | 23.2% | 21.2% | 27.6% | 30.4% | 43.6% | 49.5% | 27.7% | 31.2% |
| Net margin | 3.0% | 13.5% | 16.3% | 14.9% | 21.4% | 33.1% | 41.4% | 22.0% | 17.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.56B | $1.46B | $1.51B | $1.60B | $1.59B | $1.51B | $1.59B | $1.58B | $1.61B | $1.62B | $1.60B | $1.52B |
| Cost of revenue | $711.0M | $677.0M | $748.0M | $745.0M | $720.0M | $672.0M | $696.0M | $659.0M | $668.0M | $665.0M | $683.0M | $612.0M |
| Gross profit | $847.0M | $783.0M | $759.0M | $857.0M | $874.0M | $841.0M | $896.0M | $923.0M | $939.0M | $957.0M | $915.0M | $907.0M |
| Research & development | $90.0M | $93.0M | $91.0M | $84.0M | $95.0M | $96.0M | $130.0M | $111.0M | $116.0M | $112.0M | $134.0M | $137.0M |
| Sales, general & admin | $434.0M | $424.0M | $433.0M | $415.0M | $453.0M | $420.0M | $470.0M | $422.0M | $437.0M | $431.0M | $469.0M | $497.0M |
| Total operating expenses | $524.0M | $517.0M | $524.0M | $499.0M | $548.0M | $516.0M | $600.0M | $533.0M | $553.0M | $543.0M | $603.0M | $675.0M |
| Operating income | $323.0M | $266.0M | $235.0M | $358.0M | $326.0M | $325.0M | $296.0M | $390.0M | $386.0M | $414.0M | $312.0M | $232.0M |
| Interest expense | $108.0M | $111.0M | $121.0M | $128.0M | $132.0M | $124.0M | $132.0M | $126.0M | $131.0M | $131.0M | $129.0M | $134.0M |
| Income before taxes | $183.0M | $213.0M | −$148.0M | $243.0M | $229.0M | $101.0M | $129.0M | $207.0M | $235.0M | $236.0M | $104.0M | $80.0M |
| Income taxes | $75.0M | $67.0M | $57.0M | $83.0M | $84.0M | $14.0M | $20.0M | −$152.0M | $40.0M | $35.0M | −$442.0M | $22.0M |
| Net income | $108.0M | $146.0M | −$205.0M | $160.0M | $145.0M | $87.0M | $109.0M | $359.0M | $195.0M | $201.0M | $546.0M | $58.0M |
| EBITDA | $371.0M | $410.0M | $69.0M | $463.0M | $449.0M | $325.0M | $341.0M | $402.0M | $432.0M | $432.0M | $293.0M | $275.0M |
| EPS (diluted) | $0.80 | $0.71 | $0.63 | $1.01 | $1.00 | $1.02 | $0.90 | $0.87 | $1.12 | $1.22 | $0.88 | $0.87 |
| Gross margin | 54.4% | 53.6% | 50.4% | 53.5% | 54.8% | 55.6% | 56.3% | 58.3% | 58.4% | 59.0% | 57.3% | 59.7% |
| Operating margin | 20.7% | 18.2% | 15.6% | 22.3% | 20.5% | 21.5% | 18.6% | 24.7% | 24.0% | 25.5% | 19.5% | 15.3% |
| Net margin | 6.9% | 10.0% | −13.6% | 10.0% | 9.1% | 5.8% | 6.8% | 22.7% | 12.1% | 12.4% | 34.2% | 3.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in OGN's financial statements (latest annual report filed February 24, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
OGN financial results
In fiscal year 2025 (ended December 31, 2025), Organon reported revenue of $6.2 billion, down 2.9% from the year before. It had net income of $187.0 million (down 78.4%), a net profit margin of 3.0%. Diluted earnings per share came to $3.66. Over five years revenue grew at an average rate of −1.0% a year.
See the OGN stock overview for the latest quote and news, or the OGN chart for price history and technical indicators.
OGN income statement FAQ
What is Organon's annual revenue?
Organon reported total revenue of $6.2 billion for fiscal year 2025, which ended on December 31, 2025. That was down 2.9% from $6.4 billion the previous year.
Is Organon profitable?
Yes. Organon reported net income of $187.0 million in fiscal 2025, a net profit margin of 3.0%; its operating margin was 20.7%.
What is Organon's gross margin?
Organon's gross margin was 54.1% in fiscal 2025: for every $100 of revenue, Organon kept $54 after the direct cost of its products and services.
How much does Organon spend on research and development?
Organon spent $366.0 million on research and development in fiscal 2025, 5.9% of revenue.
How fast is Organon growing?
Revenue grew −1.0% a year on average over the last five fiscal years, from $6.5 billion to $6.2 billion.
What are Organon's earnings per share?
Organon earned $3.66 per diluted share in fiscal 2025, compared with $4.11 a year earlier.
When will Organon report its next earnings?
Organon is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 before the market opens.
When does Organon's fiscal year end?
Organon's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 24, 2026.